New Gastroparesis Treatments In Wesley Chapel, FL

Five things get called gastroparesis treatment. They’re not interchangeable.

Endoscopic pyloromyotomy (G-POEM or POP) is done through the mouth with a flexible endoscope. A tunnel is created under the pyloric muscle, the muscle is divided, and the valve stops resisting. No abdominal incisions. Most patients go home the same day and return to normal activity within days on a structured diet progression. A pooled analysis of 13 studies covering 952 patients with refractory gastroparesis reported clinical success of about 72 percent at one year, with roughly 8 percent adverse events. Among patients who succeeded at one year, about 58 percent still had success at three years. Response varies by cause, with published series reporting roughly 64 percent for diabetic, 67 percent for post-surgical, and 72 percent for idiopathic gastroparesis.

Read those numbers the way we present them in the office. Around one in four patients does not respond at a year, and the benefit erodes over time in a subset of the rest. That is why the screen exists.

Surgical pyloroplasty divides and reshapes the same valve through small abdominal incisions. The AGA made no recommendation either way here, identifying it as a knowledge gap in the evidence.

Gastric electrical stimulation (Enterra) is an implanted device. The AGA advises against routine use and reserves it for refractory patients, particularly those with nausea and vomiting as the dominant symptoms. We do not implant these devices, and if that’s the right path for you we will say so and route you appropriately.

One sequencing detail almost nobody mentions: the Enterra enhanced-programming study currently recruiting at the University of South Florida in Tampa (ClinicalTrials.gov identifier NCT06560307, sponsored by Enterra Medical) excludes anyone with a history of pyloroplasty, pyloromyotomy, or G-POEM, and excludes post-surgical gastroparesis. If a trial is something you want to keep on the table, the order you do things in matters. We will tell you that before a procedure, not after.

Feeding tubes and subtotal gastrectomy are reserved for severe malnutrition and disease that has not responded to anything else. The parent gastroparesis page covers the full range in more detail.

Medication remains the starting point for nearly everyone, and for many patients it’s also the ending point.

A gastroparesis diagnosis is often a label applied to a symptom cluster rather than a confirmed mechanism. Three patterns come through this practice repeatedly.

Post-surgical gastroparesis. Delayed emptying after foregut or bariatric surgery is a distinct category with a distinct cause, usually vagal nerve injury. It changes what to expect from a pyloric procedure and, as noted above, it changes trial eligibility. Dr. Grandhige routinely evaluates post-surgical foregut complications from operations performed elsewhere, including after fundoplication.

The large hiatal hernia nobody connected to the stomach. This is the observation Dr. Grandhige makes most often that patients have never heard. The larger a hiatal hernia gets, the more likely an atonic stomach develops, and that stomach may or may not recover after the hernia is repaired. If you have a hernia over 3 centimeters and delayed emptying, the sequence of repair versus pyloric procedure is a real clinical decision, not a formality.

Reflux and gastroparesis pointing at each other. Delayed emptying worsens reflux, and reflux symptoms get treated as gastroparesis and the reverse. Sorting the two requires objective testing rather than a symptom inventory. That’s why evaluation here includes pH monitoring, impedance testing, and esophageal manometry where indicated, the same physiologic approach used for GERD and every other foregut condition in the practice.

One more thing worth knowing: where you feel a problem is often not where it is. On a functional barium swallow, the location a patient points to matches the true anatomic location only about 60 percent of the time. A patient feels food sticking in the throat; the study shows the delay is in the distal esophagus. Testing exists because symptoms are unreliable narrators.

Here’s the schedule, start to finish.

First consultation: usually within two weeks, always within four. Send your records to info@tampareflux.com before the visit. Dr. Grandhige personally reviews prior endoscopy and pathology reports, pH studies, manometry, barium swallows, imaging, and notes from your gastroenterologist, ENT, pulmonologist, or primary care physician. Records sent in advance turn the first visit into a decision-making visit instead of a data-gathering one. He works from visual diagrams in the room, and patients consistently say the drawings are what made the condition make sense.

If your testing is already complete: one consultation. The plan can often be set that day.

If testing is needed: a second consultation roughly four weeks later to review results and finalize the plan. Two visits, deliberately. Testing is coordinated through a small number of trusted sites so results come back quickly and consistently, and whatever can be done closer to Wesley Chapel gets done there. Testing days are consolidated where possible.

Insurance authorization runs four to six weeks and our office handles the entire submission. Patients who call their own insurer usually slow this down rather than speed it up.

Total: roughly four to eight weeks from first consultation to procedure, depending on where your testing stands.

Procedures are performed at HCA South Tampa Hospital, the only hospital Dr. Grandhige operates at. The same anesthesia team, nursing staff, and surgical technologists work with him on every case. A physician assistant he employs directly assists in every procedure, knows your anatomy and your operation, and stays involved through your recovery. After hours, you reach Dr. Grandhige himself, not an answering service.

Medically reviewed by Gopal Grandhige, MD, FACS Board-Certified General Surgeon. Founder and Medical Director, Tampa Bay Reflux Institute. Fellowship training in Foregut and Minimally Invasive Surgery, Yale-New Haven Hospital. General Surgery Residency, Yale-New Haven Hospital. MD, University of Michigan. BS Biology, Johns Hopkins University. Founding Member, American Foregut Society. Member, Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Fellow, American College of Surgeons. Practicing foregut surgery in Tampa Bay since 2009. Board certification is verifiable through the American Board of Surgery physician lookup and active Florida licensure through the Florida Department of Health Medical Quality Assurance license lookup.